Macular telangiectasia

From WikiMD's WELLNESSPEDIA

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Macular telangiectasia
Synonyms MacTel, Idiopathic juxtafoveal telangiectasia
Pronounce N/A
Specialty N/A
Symptoms Visual impairment, metamorphopsia, scotoma
Complications Retinal detachment, neovascularization
Onset Middle age
Duration Chronic
Types Type 1 (aneurysmal), Type 2 (perifoveal), Type 3 (occlusive)
Causes Unknown, possibly genetic and environmental factors
Risks Diabetes, hypertension, smoking
Diagnosis Ophthalmoscopy, fluorescein angiography, optical coherence tomography
Differential diagnosis Age-related macular degeneration, central serous retinopathy, retinal vein occlusion
Prevention None
Treatment Anti-VEGF therapy, laser photocoagulation, vitamin supplementation
Medication N/A
Prognosis Variable, often progressive
Frequency Rare
Deaths N/A


Schematic diagram of the human eye

Macular Telangiectasia (MacTel) is a disease that affects the macula, the part of the eye responsible for detailed, central vision. The disease is characterized by telangiectasia, or abnormal blood vessels, in the macula.

Symptoms[edit]

The symptoms of Macular Telangiectasia can vary, but often include:

  • Blurred vision
  • Distorted vision
  • Trouble reading or performing tasks that require the ability to see detail
  • A blind spot in the center of the visual field

Causes[edit]

The exact cause of Macular Telangiectasia is unknown, but it is thought to be related to changes in the blood vessels of the macula. Some researchers believe that it may be caused by a combination of genetic and environmental factors.

Diagnosis[edit]

Macular Telangiectasia is diagnosed through a comprehensive eye examination. This may include:

Treatment[edit]

There is currently no cure for Macular Telangiectasia. Treatment focuses on managing the symptoms and slowing the progression of the disease. This may include:

Prognosis[edit]

The prognosis for individuals with Macular Telangiectasia varies. Some people may experience a slow progression of the disease, while others may experience a rapid loss of vision.

See also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.